Financial Toxicity in Colorectal Cancer Patient Who Received Localized Treatment in the Veterans Affairs Health SystemSeptember 1, 2022Colon and RectalOncology
Castration-Resistant Prostate Cancer—Not Only Challenging to Treat, but Difficult to DefineAugust 30, 2022Colon and RectalOncology
Identification of Clinically Actionable Genomic Alterations in Colorectal Cancer Patients From the VA National Precision Oncology Program (NPOP)August 30, 2022Colon and RectalOncology
Evaluation of the Prostate Cancer Molecular Testing Pathway (PCMTP) Within the Veterans Health Administration (VHA)August 30, 2022Colon and RectalOncology
New Delivery Models Improve Access to Germline Testing for Patients With Advanced Prostate CancerAugust 30, 2022Colon and RectalOncology
Utilization of Next Generation Sequencing in Metastatic Colorectal CancerAugust 30, 2022Colon and RectalOncology
Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access SettingAugust 11, 2022Colon and RectalOncologyProstate Cancer
US Multi-Society Task Force lowers recommended CRC screening ageDecember 21, 2021CancerOncologyColon and Rectal
Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-free DNASeptember 10, 2021Prostate CancerColon and RectalOncology
Methods of Identifying Real World mCRPC Patients from the Veterans Health Administration SystemSeptember 9, 2021Prostate CancerColon and Rectal
